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To the Editor Protein C is a vitamin K‑dependent 
plasma glycoprotein precursor of the serine pro‑
tease, activated protein C, which is a natural an‑
ticoagulant protein.1 Protein‑C deficiency is clas‑
sified as type I (quantitative defects of protein 
C: low antigen levels, reduced activity) and type 
II (qualitative defects of protein C: normal anti‑
gen concentrations, reduced activity).2 The preva‑
lence of protein C deficiency is estimated at 0.5% 
in the general population.3
Protein C is encoded by the protein C gene 
(PROC) located on chromosome 2q13‑q14. PROC 
is approximately 11kb‑long and comprises 9 ex‑
ons.1 Heterozygous protein C deficiency is asso‑
ciated with deep vein thrombosis (DVT) and/or 
pulmonary embolism (PE), occurring spontane‑
ously or triggered, for example, by trauma.4
Here we report a case of protein C deficiency 
resulting from PROC C106R (HGVS numbering 
system) missense mutation diagnosed in a young 
Polish man with provoked DVT and PE.
A 29‑year‑old man experienced first‑ever proxi‑
mal DVT of the left leg following trauma and sub‑
sequent high‑risk PE with hypotonia that was suc‑
cessfully treated with tenecteplase. The patient 
started therapy with acenocoumarol with a tar‑
get international normalized ratio value of 2 to 3. 
His family history of DVT and PE was negative. 
The patient was obese (97 kg, 178 cm). No other 
risk factors for DVT were observed. An 18‑month 
follow‑up while on anticoagulant therapy was 
uneventful.
While taking enoxaparin for 2 weeks, the pa‑
tient was screened for thrombophilia. Plasma pro‑
tein C activity was quantified using the HemosIL 
Protein C chromogenic assay (Instrumentation 
Laboratory, Milan, Italy) and protein C antigen 
was measured by an enzyme‑linked immunosor‑
bent assay (Asserachrome Protein C, Diagnosti‑
ca Stago, Asnieres, France). On 2 separate occa‑
sions, protein C activity was 42% (reference range, 
70%–140%), while protein C antigen was 44% and 
41%, respectively (reference range, 65%–140%). 
Transient causes of low protein C concentrations 
were excluded. Type I protein C deficiency was 
established. Other thrombophilic factors were 
absent.
After obtaining written informed consent from 
the patient, genomic DNA was extracted from 
whole blood collected in EDTA. All exons and the 
exon–intron boundaries of the PROC gene were 
subjected to direct sequencing.5
A heterozygous nucleotide substitution T>C 
was found in codon 106 resulting in the replace‑
ment of cysteine by arginine (C106R) at the pro‑
tein level. This mutation is predicted to be det‑
rimental given its position and the amino acid 
change (PolyPhen2 score 1; genetics.bwh.har‑
vard.edu/pph2). There was no other mutation 
in the exons or flanking introns of the PROC 
gene. Other family members were unavailable 
for analysis.
To the best of our knowledge, a missense 
C106R mutation in the PROC gene has not been 
reported in the literature. Another missense mu‑
tation at the same position, cysteine‑to‑tryp‑
tophan substitution (C106W, designated as PC 
Shanghai), was detected in a 32‑year‑old wom‑
an diagnosed with DVT.6 The current Polish pa‑
tient with protein C deficiency had massive DVT 
complicated by PE requiring fibrinolytic therapy, 
which was likely due to the combined effect of 
genetic and transient risk factors. To our knowl‑
edge, this case is the second genetically charac‑
terized protein C deficiency in a Polish patient.7
Molecular modeling studies suggested that 
the consequences of single nucleotide substi‑
tutions leading to amino acid changes within 
the coding region of PROC are improper folding 
of the mutant proteins2 as well as their impaired 
secretion and partial intracellular degradation 
through the proteosome pathway.6 In some pop‑
ulations, i.e., Finnish, Dutch, or Japan, charac‑
teristic missense mutations have been described, 
suggesting the presence of the founder effect.2
Our report supports the view that screen‑
ing for inherited thrombophilia should be con‑
ducted in young patients with extensive venous 
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thromboembolism, in particular high‑risk PE, 
even if a family history is negative.
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